vs
Side-by-side financial comparison of AVNET INC (AVT) and Bristol Myers Squibb (BMY). Click either name above to swap in a different company.
Bristol Myers Squibb is the larger business by last-quarter revenue ($11.5B vs $7.1B, roughly 1.6× AVNET INC). Bristol Myers Squibb runs the higher net margin — 23.3% vs 1.3%, a 22.0% gap on every dollar of revenue. On growth, AVNET INC posted the faster year-over-year revenue change (12.7% vs 11.0%). Over the past eight quarters, AVNET INC's revenue compounded faster (12.7% CAGR vs -3.0%).
Avnet, Inc. is a distributor of electronic components headquartered in Phoenix, Arizona, named after Charles Avnet, who founded the company in 1921. After its start on Manhattan's Radio Row, the company became incorporated in 1955 and began trading on the New York Stock Exchange in 1961. On May 8, 2018, Avnet changed stock markets to Nasdaq, trading under the same ticker AVT.
Bristol-Myers Squibb Company, doing business as Bristol Myers Squibb, is an American multinational pharmaceutical company headquartered in Princeton, New Jersey. The company's primary products are apixaban (Eliquis) for people with atrial fibrillation ; nivolumab (Opdivo), used to treat certain types of cancer ; lenalidomide (Revlimid), used to treat multiple myeloma, smoldering myeloma, and myelodysplastic syndromes ; abatacept (Orencia), used to treat autoimmune diseases such as rheumatoid art...
AVT vs BMY — Head-to-Head
Income Statement — Q3 FY2026 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $7.1B | $11.5B |
| Net Profit | $94.3M | $2.7B |
| Gross Margin | 10.4% | — |
| Operating Margin | 2.9% | — |
| Net Margin | 1.3% | 23.3% |
| Revenue YoY | 12.7% | 11.0% |
| Net Profit YoY | -59.7% | 8.8% |
| EPS (diluted) | $1.14 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q3 26 | $7.1B | — | ||
| Q1 26 | — | $11.5B | ||
| Q4 25 | $6.3B | $12.5B | ||
| Q3 25 | $5.9B | $12.2B | ||
| Q2 25 | $5.6B | $12.3B | ||
| Q1 25 | $5.3B | $11.2B | ||
| Q4 24 | $5.7B | $12.3B | ||
| Q3 24 | $5.6B | $11.9B |
| Q3 26 | $94.3M | — | ||
| Q1 26 | — | $2.7B | ||
| Q4 25 | $61.7M | $1.1B | ||
| Q3 25 | $51.7M | $2.2B | ||
| Q2 25 | $6.1M | $1.3B | ||
| Q1 25 | $87.9M | $2.5B | ||
| Q4 24 | $87.3M | $72.0M | ||
| Q3 24 | $59.0M | $1.2B |
| Q3 26 | 10.4% | — | ||
| Q1 26 | — | — | ||
| Q4 25 | 10.5% | 67.2% | ||
| Q3 25 | 10.4% | 71.9% | ||
| Q2 25 | 10.6% | 72.5% | ||
| Q1 25 | 11.1% | 72.9% | ||
| Q4 24 | 10.5% | 61.0% | ||
| Q3 24 | 10.8% | 75.1% |
| Q3 26 | 2.9% | — | ||
| Q1 26 | — | — | ||
| Q4 25 | 2.3% | 11.8% | ||
| Q3 25 | 2.4% | 25.5% | ||
| Q2 25 | 1.3% | 14.5% | ||
| Q1 25 | 2.7% | 26.5% | ||
| Q4 24 | 2.7% | 1.4% | ||
| Q3 24 | 2.5% | 14.1% |
| Q3 26 | 1.3% | — | ||
| Q1 26 | — | 23.3% | ||
| Q4 25 | 1.0% | 8.7% | ||
| Q3 25 | 0.9% | 18.0% | ||
| Q2 25 | 0.1% | 10.7% | ||
| Q1 25 | 1.7% | 21.9% | ||
| Q4 24 | 1.5% | 0.6% | ||
| Q3 24 | 1.1% | 10.2% |
| Q3 26 | $1.14 | — | ||
| Q1 26 | — | — | ||
| Q4 25 | $0.75 | $0.54 | ||
| Q3 25 | $0.61 | $1.08 | ||
| Q2 25 | $0.09 | $0.64 | ||
| Q1 25 | $1.01 | $1.20 | ||
| Q4 24 | $0.99 | $0.05 | ||
| Q3 24 | $0.66 | $0.60 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $202.4M | $9.6B |
| Total DebtLower is stronger | $2.9B | $-42.2B |
| Stockholders' EquityBook value | $5.0B | — |
| Total Assets | $13.5B | — |
| Debt / EquityLower = less leverage | 0.59× | — |
8-quarter trend — quarters aligned by calendar period.
| Q3 26 | $202.4M | — | ||
| Q1 26 | — | $9.6B | ||
| Q4 25 | $286.5M | $10.2B | ||
| Q3 25 | $175.5M | $15.7B | ||
| Q2 25 | $192.4M | $12.6B | ||
| Q1 25 | $188.9M | $10.9B | ||
| Q4 24 | $172.1M | $10.3B | ||
| Q3 24 | $267.5M | $7.9B |
| Q3 26 | $2.9B | — | ||
| Q1 26 | — | $-42.2B | ||
| Q4 25 | — | $44.8B | ||
| Q3 25 | — | $48.7B | ||
| Q2 25 | — | $48.9B | ||
| Q1 25 | — | $49.5B | ||
| Q4 24 | — | $49.4B | ||
| Q3 24 | — | $49.5B |
| Q3 26 | $5.0B | — | ||
| Q1 26 | — | — | ||
| Q4 25 | $4.9B | $18.5B | ||
| Q3 25 | $4.8B | $18.6B | ||
| Q2 25 | $5.0B | $17.4B | ||
| Q1 25 | $4.9B | $17.4B | ||
| Q4 24 | $4.8B | $16.3B | ||
| Q3 24 | $5.0B | $17.1B |
| Q3 26 | $13.5B | — | ||
| Q1 26 | — | — | ||
| Q4 25 | $13.2B | $90.0B | ||
| Q3 25 | $12.4B | $96.9B | ||
| Q2 25 | $12.1B | $94.7B | ||
| Q1 25 | $11.7B | $92.4B | ||
| Q4 24 | $11.9B | $92.6B | ||
| Q3 24 | $12.6B | $93.7B |
| Q3 26 | 0.59× | — | ||
| Q1 26 | — | — | ||
| Q4 25 | — | 2.43× | ||
| Q3 25 | — | 2.63× | ||
| Q2 25 | — | 2.81× | ||
| Q1 25 | — | 2.85× | ||
| Q4 24 | — | 3.03× | ||
| Q3 24 | — | 2.89× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
AVT
| Electronic Components | $6.7B | 94% |
| Farnell | $454.7M | 6% |
BMY
Segment breakdown not available.
